Save up -80% on Levomilnacipran
|Note: this is a drug discount program, not an insurance plan.|
|RX BIN: 015558||RX PCN: HT||Group ID: DDN6600||Card Holder ID: DDN6600|
|Pharmacists and Patients support.|
2019 Price of Fetzima
|$406.11||30 capsules/40 mg|
|price without discount in nearest pharmacy. Price may vary.|
We offer free Fetzima coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your manufacturer copay card in most local pharmacies to get a discount on Levomilnacipran every time. What are you waiting for? Claim your prescription drug card now!
Get your Prescription
It’s safe and free
Buy drugs in pharmacy
Save money each time
Levomilnacipran volume of distribution
* 387 – 473 L[apparent volume of distribution]
Discount Cards 16,000+
Clients Benefit 29%
Total savings $4,735,080
What is Levomilnacipran
Levomilnacipran mechanism of action
The exact mechanism of the antidepressant action of levomilnacipran is unknown but is thought to be related to the potentiation of serotonin and norephinephrine in the central nervous system through inhibition of reuptake at serotonin and norepinephrine transporters.
Dosage forms of Levomilnacipran
Actavis Specialty Pharmaceuticals Co
Humans and other mammals
Indication of Levomilnacipran
Levomilnacipran is a serotonin and norepinephrine reuptake inhibitor and is indicated for the treatment of major depressive disorder (MDD).
RX24 Drugs Disclaimer: consult your healthcare provider before buying a Levomilnacipran on prescription or using an RX manufacturer savings coupon. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.
Get lower price on Levomilnacipran now!
What is Fetzima?
Fetzima is a selective antidepressant for serotonin and norepinephrine reuptake inhibitor (SNRI). Fetzima affects chemicals in the brain that may be unbalanced in people with depression.
Fetzima is used to treat major depressive disorder. A similar medicine called milnacipran (Savella) is used to treat a chronic pain disorder called fibromyalgia. Fetzima should not be used to treat fibromyalgia.
You should not use Fetzima if you have untreated or uncontrolled narrow-angle glaucoma. Do not use Fetzima if you have taken an MAO inhibitor in the last 14 days. Dangerous drug interactions can occur. MAO inhibitors include isocarboxazid, linezolid, methylene blue injection, fenelzine, rasagiline, selegiline, and tranylcypromine. Do not use a MAO inhibitor for 7 days after stopping this drug.
Some young people have thoughts about suicide when they first take an antidepressant. Your doctor will need to check your progress with regular visits while you are using Fetzima. Report any new or worsening symptoms to your doctor, such as: changes in mood or behavior, anxiety, panic attacks, sleep problems, or if you feel impulsivity, irritability, agitation, hostility, aggression, anxiety, hyperactivity (mentally or physically). Do not give this medicine to anyone under 18 without consulting a doctor. Fetzima is not approved for use in children.